AMRUTAJAN HEALTH LTD

310.5 +0.75 (+0.24%) Buy

AMRUTANJAN investors looking to add more to current positions

13 min read

AMRUTAJAN HEALTH LTD managed to outperform the broader market today. It surged by +0.24% to close at 310.5. It's recent 5 day performance has been +3.89%, +0.02%, +1.0%, +1.76% and -0.68%.

[Themes containing AMRUTANJAN]

AMRUTANJAN is currently in a bullish trend. Over the last three months 3 bullish signals in AMRUTANJAN have generated a profit of +12.39% for investors.

Trend

AMRUTANJAN has been outperforming the NIFTY-50 index in recent time. It showed significant underperformance (compared to the NIFTY-50 index) from 15 May, 2017 to 20 Aug, 2018. Over the last 3 years and 1 month, AMRUTANJAN underperformed the NIFTY-50 index on 54% days.

AMRUTANJAN returned losses on 54% days in the last three months. During this time, it delivered on average +0.39% per day. It delivered it's best daily return of +14.51%, during this period, on Friday, 21 Dec, 2018. The longest stort-term trends during this period were 5 profitable and losing days. The bullish trend (which returned +18.9%) started on 17 Dec, 2018 and went on till 21 Dec, 2018 while the bearish trend (which returned -3.37%) started on 20 Nov, 2018 and went on till 27 Nov, 2018.

The last 12 months saw AMRUTANJAN's investors making profits in 6 months and incurring losses in 6 months. During the last year, AMRUTANJAN delivered profits in more months than NIFTY-50 index. AMRUTANJAN was also a more risky investment than NIFTY-50 index as it's worst month in the last year, Sep 2018, returned -19.61% compared to -6.42% returned by NIFTY-50 index in Sep 2018. AMRUTANJAN and NIFTY-50 index, both had periods of 2 consecutive profitable months. It is interesting to note that both AMRUTANJAN and NIFTY-50 index significantly outperform during months when quarterly/annual results are announced.

"Confronted with a challenge to distill the secret of sound investment into three words, we venture the motto, Margin of Safety.

AMRUTANJAN is currently seeing overall increase in volatility. In comparison, the NIFTY-50 index is seeing decrease in volatility. During the last three months, there was a significant surge in AMRUTANJAN's volatility from 22 Oct, 2018 to 30 Oct, 2018. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that AMRUTANJAN has significant negative skewness in it's return distribution. This indicates that AMRUTANJAN is very risky for short-term investment and can significantly underperform for long durations.

NIFTY-50 index has more chance of extreme outcomes than AMRUTANJAN. Therefore, NIFTY-50 must receive a lower allocation than AMRUTANJAN in your portfolio. NIFTY-50 index usually has shorter drawdown period than AMRUTANJAN.

Based on your interest in AMRUTANJAN you may find it interesting to know that BRITANNIA is a large cap that has shown remarkable performance and deserves to be on every investors' watchlist.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter